Loading…
Carroll-Baccari, Inc., operating as Mavidon Medical Products, received an FDA Warning Letter on April 17, 2020, regarding medical devices. Based on the limited metadata available, the specific nature of the violations cannot be determined as no subject line or detailed information was provided. The warning was issued by the FDA's medical devices division, though the specific issuing office is not identified in the available metadata. A review of the complete warning letter would be necessary to understand the particular compliance issues cited.